Article R1123-2
Any change concerning the information mentioned inarticle R. 1123-1 is communicated by the Chairman of the Committee to the Director General of the Regional Health Agency.
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 21–30 of 151 articles for “Art. 1123”
Any change concerning the information mentioned inarticle R. 1123-1 is communicated by the Chairman of the Committee to the Director General of the Regional Health Agency.
The Committee gives its opinion under the conditions set out in Article R. 1123-23. If the Committee's opinion is unfavourable, the sponsor may not implement the modification to the research.
…entation and the content of the request for modification of the research provided for in article L. 1123-9 , the clinical investigation provided for in article L. 1125-3 or the performance study provi…
…estigator(s). These records shall be transmitted to the competent authority mentioned in Article L. 1123-12, at its request.
In application of the third paragraph of article L. 1123-11, except in the case of imminent risk, the sponsor has a period of one week in which to submit its observations from receipt of the request t…
…l of the Regional Health Agency will replace the member under the conditions laid down inarticle R. 1123-8.
For the research mentioned in 1° of Article L. 1121-1 other than that mentioned in Articles R. 1123-54 to R. 1123-58, the sponsor must report to the competent authority any suspected serious unexpecte…
The competent authority defined in Article L. 1123-12 implements the vigilance system relating to research involving the human person. Where necessary, it shall take appropriate measures to ensure the…
…the human person :1° The protocol for research involving the human person referred to in Article R. 1123-20 ; 2° Where applicable, the pharmaceutical form, batch number(s) and expiry date of the medic…
…form, content and procedures for reporting adverse reactions and new facts as defined in Article L. 1123-10 and, where applicable, the procedures for lifting the blind shall be laid down by decision o…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More